Interestingly, terazosin, a hypertension medication that is secondarily found to activate another glycolytic enzyme, phosphoglycerate kinase (PGK), is now considered a potential drug for PD [107,108]; here terazosin was found to alleviate α-syn accumulation and neurotoxicity in a few PD models [107]. This evidence concerns the gene HK1 and Parkinson disease.